Cardiovascular · Drug monograph
Captopril: veterinary dose and monograph
Captopril is a veterinary cardiovascular drug. The first ACE inhibitor — a SHORT-acting agent for congestive heart failure and hypertension. Indications include congestive heart failure (with diuretics ± pimobendan); systemic hypertension; proteinuric kidney disease (reduces proteinuria). This monograph lists 2 reference doses for dogs and cats, each with route, frequency and source.
At a glance
- Drug class
- Cardiovascular
- Also known as
- Capoten, Aceten, Angiopril
- Species with doses
- Dogs and Cats
- General dose range
- 0.5–2 mg/kg PO q8–12h — check the species tables for the indication
- Routes
- PO
- Last reviewed
- 1 October 2026
Indications
- Congestive heart failure (with diuretics ± pimobendan)
- Systemic hypertension
- Proteinuric kidney disease (reduces proteinuria)
- Afterload reduction (largely superseded by longer-acting ACE inhibitors)
Captopril dose by species
Doses are per administration unless stated. mg/kg doses scale with body weight; per-animal, per-quarter and infusion-rate doses are shown as the reference writes them.
Dogs
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| CHF / hypertension | 0.5–2 mg/kg | PO | q8–12h | — |
- CHF / hypertension: Papich 5e and Plumb’s p.189: 0.5–2 mg/kg PO q8–12h (Atkins — three times daily). Enalapril, benazepril and other newer ACE inhibitors have largely replaced it. Start low with diuretics; monitor creatinine and potassium.
Cats
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Hypertension / CHF | 0.55–1.54 mg/kg | PO | q8–12h | — |
- Hypertension / CHF: Plumb’s p.189: cardiomyopathy 0.55–1.54 mg/kg PO q8–12h (Kittleson); ¼–½ of a 12.5 mg tablet q8–12h (Bonagura). Papich 5e: 3.12–6.25 mg per cat q8h. Monitor renal values and potassium.
Contraindications
Bilateral renal artery stenosis, pre-existing hypotension, dehydration/hypovolaemia, hyperkalaemia, and outflow-tract obstruction. Pregnancy (ACE-inhibitor fetotoxicity). Caution with other RAAS drugs/diuretics. Known ACE-inhibitor hypersensitivity.
Adverse effects
- Hypotension (especially first dose with diuretics)
- Azotaemia / reduced GFR; hyperkalaemia
- GI upset (vomiting, anorexia)
- Short duration → frequent dosing needed
Drug interactions
- Diuretics (furosemide): additive hypotension/azotaemia — start low, monitor
- Potassium-sparing diuretics/K supplements: hyperkalaemia
- NSAIDs: blunt effect and increase nephrotoxicity
- Other antihypertensives: additive hypotension
Pregnancy and lactation
Contraindicated in pregnancy — ACE inhibitors are fetotoxic.
Monitoring
- Renal values and potassium at baseline and after starting/changes
- Blood pressure; resting respiratory rate (CHF)
- Urine protein:creatinine in proteinuric patients
Toxicity and overdose
Overdose: hypotension, weakness, azotaemia, hyperkalaemia — as for the ACE-inhibitor class. First-dose hypotension and renal decompensation (with aggressive diuretics/volume depletion) are the main hazards.
Management: No specific antidote. IV fluids for hypotension (cautiously in cardiac patients), treat hyperkalaemia, support renal function; vasopressors if refractory. Monitor renal values and electrolytes.
Clinical pearls
- The original ACE inhibitor, now largely a historical/second choice — its short duration means q8–12h dosing, whereas enalapril/benazepril/ramipril give once/twice-daily convenience
- Same class benefits and cautions as other ACE inhibitors (start low with diuretics; watch renal values/potassium)
- Prefer a longer-acting ACE inhibitor for routine CHF/hypertension/proteinuria management
Mechanism of action
Inhibits angiotensin-converting enzyme, blocking conversion of angiotensin I to angiotensin II and reducing aldosterone — producing arteriolar/venous dilation (reduced afterload/preload), lower blood pressure, reduced sodium/water retention, and lower intraglomerular pressure (decreasing proteinuria). Reduced bradykinin breakdown adds to vasodilation. Its short half-life necessitates frequent dosing.
Formulations and products
- 12.5 / 25 mg tablet
- 50 mg tablet
- Capoten / Angiopril — 12.5 / 25 / 50 mg tablet, Tablet (human-label)
Storage
Tablets: 15–30 °C, dry, protect from light/moisture.
Before you use this dose
Reference doses for veterinary professionals. Confirm the dose against the product label, the patient’s condition, current guidance and local regulations before use; the attending veterinarian remains responsible for every clinical decision.
Frequently asked questions
What is the dose of Captopril for dogs?
Reference doses for Captopril in dogs: 0.5–2 mg/kg PO q8–12h (CHF / hypertension). Confirm against the label and the patient before use.
What is the dose of Captopril for cats?
Reference doses for Captopril in cats: 0.55–1.54 mg/kg PO q8–12h (Hypertension / CHF). Confirm against the label and the patient before use.
When should Captopril not be used?
Bilateral renal artery stenosis, pre-existing hypotension, dehydration/hypovolaemia, hyperkalaemia, and outflow-tract obstruction. Pregnancy (ACE-inhibitor fetotoxicity). Caution with other RAAS drugs/diuretics. Known ACE-inhibitor hypersensitivity.
What are the side effects of Captopril in animals?
Hypotension (especially first dose with diuretics); Azotaemia / reduced GFR; hyperkalaemia; GI upset (vomiting, anorexia); Short duration → frequent dosing needed.
Sources
- Plumb's Veterinary Drug Handbook
- Merck Veterinary Manual, 11th edition
- Papich, Papich Handbook of Veterinary Drugs, 5th edition
Last reviewed · VetMasterJi